BLOOD VESSEL DENSITY AS A PREDICTOR IN ORAL SQUAMOUS CELL CARCINOMA USING CD34

Authors

1 -Instructor in Oral Pathology Department, Faculty of Dentistry, Alexandria University.

2 -Professor in Oral Pathology Department.

3 Professor in Oral Pathology Department

4 Professor in Cranio Maxillofacial and Plastic Surgery.

Abstract

INTRODUCTION: Oral squamous cell carcinoma (OSCC) accounts for more than 90% of all oral cancers. Despite advances in the approach to locally advanced disease, about 50% of the tumors will recur. Fifty percent of patients present nodal involvement that is detectable during diagnosis. Of this group, less than 40% survive after five years, compared with a 90% survival rate for patients without metastasis. If the lesion is detected at an early stage and treated effectively, the survival rate could exceed 50%. Many retrospective studies have shown that microvessel density (MVD) could represent a valid independent prognostic factor for the overall survival. The blood vessel density may constitute a relevant parameter for determining the prognosis and guiding biological treatments for aggressive OSCC OBJECTIVES: To assess the MVD using CD34 in lymph node positive and negative cases and to correlate the results with the lymph node status. MATERIALS AND METHODS: MVD was calculated in 22 surgical specimens taken from OSCC patients. Biopsies were taken from the primary tumor of eleven cases proved to have positive lymph node and eleven cases with negative lymph nodes. Immunohistochemical (IHC) staining was performed using a Labeled Strept-Avidin Biotin complex method (LSAB), using the CD34 antibody. RESULTS: OSCC biopsies showed immunoreactivity to CD34, the difference between the mean MVD and lymph node status was significantly correlated. No significant relation with the histological grade site was found. CONCLUSIONS: MVD was significantly correlated with lymph node status and it could be used as an indicator for progression and early metastasis of OSCC. But, no correlation was found between the MVD and the histological grading.

Keywords

Main Subjects

References

  1. Siegel R, Ma J, Zou Z, Jemal A Cancer statistics, 2014. CA Cancer J Clin .2014;64:9-29.
  2. Vermorken J, Mesia R, Rivera F, Remenar E, Kawecki A, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med.2008; 359: 1116-27.
  3. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007; 26: 645- 62.
  4. Grimm M. Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: Microvascular invasion (V+) is an independent prognostic factor for OSCC. Clin Transl Oncol 2012; 14: 870-80.
  5. Pianka A, Knosel T, Probst F, Troeltzsch M, Woodlock T, Otto S, et al. Vascular endothelial growth factor receptor isoforms: are they present in oral squamous cell carcinoma? Journal of Oral and Maxillofacial Surgery. 2015;73:897-904.
  6. Liping S, Ying W, Mingzhen X, Yuan L, Lei Y. Upregulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2010;110:484-91.
  7. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature. 1980; 288:551–6.
  8. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1:27–31.
  9. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res 1986; 46: 467-73.
  10. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst.1990; 82:4–6.
  11. Weinder N. Tumor vascularity as a prognostic factor in cancer patients: The evidence continues to grow. J Pathol 1998; 184:119-22.
  12. Macchinarini P, Fontanini G, Hardin MJ, Squatini F, Angeletti CA. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 1992; 340:145-6.
  13. Weinder N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
  14. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma cancer 1994; 73:678-87.
  15. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990; 75: 2417-26.
  16. Nielsen JS, McNagny KM. Novel functions of the CD34 family. Journal of Cell Science. 2008;121:3683-92.
  17. Ettl T, Hautmann M, Reichert TE, Bauer R. Cycling CD34 expression in subpopulations of head and neck squamous cell carcinoma cell lines is involved in radioresistance and change in cytokeratin expression profile. Clinical and experimental medicine. 2017;17:565-74.
  18. Mashhadiabbas F, Mahjour F, Mahjour SB, Fereidooni F, Hosseini FS. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: 240-50.
  19. Miyahara M, Tanuma Ji, Sugihara K, Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer. 2007;110:1287-94.
  20. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med. 1989;18:432-7.
  21. Shieh YS, Lee HS, Shiah SG, Chu YW, Wu CW, Chang LC. Role of angiogenic and non angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. Journal of Oral Pathology & Medicine. 2004;33:601-6.
  22. Safwat M, Habib F, Elayat A, Oweiss N, Reffat S, Algaidi S. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinomas of the human breast. Folia Morphologica. 2009;68:144-55.
  23. Gasparini G. Prognostic and predictive value of intratumoral microvessel density in human solid tumours. Tumour Angiogenesis. 1997:29-44.
  24. Chien CY, Su CY, Hwang CF, Chuang HC, Hsiao YC, Wu SL, et al. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx. Head & Neck. 2006;28:441-6.
  25. Dales J-P, Garcia S, Bonnier P, Duffaud F, Andrac-Meyer L, Ramuz O, et al. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas: correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients. American Journal of Clinical Pathology. 2003;119:374-80.
  26. Wikström P, Lissbrant IF, Stattin P, Egevad L, Bergh A. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. The Prostate. 2002;51:268-75.
  27. Srivastava A, Laidler P, Davies R, Horgan K, Hughes L. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. The American Journal of Pathology. 1988;133:419.
  28. Fox SB, Gatter KC, Harris AL. Tumour angiogenesis. The Journal of Pathology. 1996;179:232-7.
  29. Page DL, Jensen RA. Angiogenesis in human breast carcinoma: what is the question?: WB Saunders; 1995.
  30. Lindmark G, Gerdin B, Sundberg C, Påhlman L, Bergström R, Glimelius B. Prognostic significance of the microvascular count in colorectal cancer. Journal of Clinical Oncology. 1996;14:461-6.
  31. de Carvalho Fraga CA, de Oliveira MVM, de Oliveira ES, Barros LO, Domingos PLB, Gomes ÉPP, et al. prognostic value of intratumoral cd57+ t cells and microvessel density in head and neck squamous cell carcinoma. Archives of Oral Research. 2017;6.
  32. Astekar M, Joshi A, Ramesh G, Metgud R. Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis. Journal of Oral and Maxillofacial Pathology: JOMFP. 2012;16:22.
  33. Tae K, El-Naggar AK, Yoo E, Feng L, Lee JJ, Hong WK, et al. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clinical Cancer Research. 2000;6:2821-8.
  34. de Sousa SF, Gleber-Netto FO, de Oliveira-Neto HH, Batista AC, Abreu MHNG, de Aguiar MCF. Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes. Applied Immunohistochemistry & Molecular Morphology. 2012;20:588-94.
  35. Riedel F, Götte K, Bergler W, Rojas W, Hörmann K. Expression of basic fibroblast growth factor protein and its down regulation by interferons in head and neck cancer. Head & Neck. 2000;22:183-9.
  36. Tan ZZ, Hossain MZ, Ahsan MS, Chew YC. Microvessel density in different grades of oral squamous cell carcinoma and its relationship with keratin pearl. Sains Malaysiana. 2016;45:201-5.
  37. Xia X, Du R, Zhao L, Sun W, Wang X. Expression of AEG-1 and microvessel density correlates with metastasis and prognosis of oral squamous cell carcinoma. Human Pathology. 2014;45:858-65.
  38. Zhao D, Pan J, Li XQ, Wang XY, Tang C, Xuan M. Intratumoral lymphangiogenesis in oral squamous cellcarcinoma and its clinicopathological significance. J Oral Pathol Med. 2008;37:616-25.
  39. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-64.

Files

Share

How to cite

Statistics